Qi has over eight years of experience in assisting clients on patent matters. She has handled more than 100 opinion matters in the areas of pharmaceuticals, chemicals and medical devices. She prepares infringement, validity and freedom-to-operate opinions relating to filings of Abbreviated New Drug Applications and 505(b)(2) New Drug Applications by a generic drug manufacturer. She also prepares and prosecutes patent applications in various technical areas, including small molecule pharmaceuticals, biologics, antibodies, vaccines, diagnostic assays, personalized medicine, food products, polymers, fuel cells, and medical devices.
Early in her career, she conducted research on ion channel regulation by phospholipids at Mount Sinai School of Medicine. Qi has extensive experience in the areas of biochemistry, protein chemistry, pharmacology, physiology, molecular biology and cell biology.
Articles in the National Law Review database by Qi Zhao, Ph.D.